首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1550565

分子診斷市場：按產品類型、按應用、按最終用戶、按地區

Molecular Diagnostics Market, By Product Type, By Application, By End-User, By Geography

出版日期: 2024年08月14日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球分子診斷市場預計到2024年將達到163.3億美元，預計2031年將達到365.5億美元，2024年至2031年複合年成長率為12.2%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	163.3億美元
實際資料	2019-2023	預測期	2024-2031
預測 2024-2031 年複合年成長率：	12.20%	2031年價值預測	365.5億美元

圖：2024 年按地區分類的分子診斷市場佔有率(%)

分子診斷是一個不斷發展的領域，它在分子層面上分析生物標記（biomarkers），以測試疾病、預測風險並確定新的治療方法。分子診斷已成為現代醫療保健的基本工具，幫助臨床醫生檢測和監測疾病並確定治療策略。透過 DNA定序和聚合酵素鏈鎖反應(PCR) 等技術檢測生物標記的能力徹底改變了醫學檢測並大大改善了患者的治療結果。分子診斷技術的進步，加上基因定序成本的下降，正在推動其在各種應用領域的廣泛使用，包括傳染病檢查、腫瘤學和個人化醫療。持續的研究和開發預計將進一步擴大分析能力，並有助於持續的市場擴張。

市場動態：

由於多種因素，全球分子診斷市場正在經歷強勁成長。世界各地的慢性病和感染疾病不斷增加，增加了對先進診斷技術的需求。分子診斷測試可以比傳統方法更快、更準確地檢測疾病。對個人化醫療和伴同性診斷不斷成長的需求也是一個關鍵促進因素，因為分子測試有助於為個別患者確定最有效的治療方法。隨著技術的進步，分子診斷能力不斷擴展，實現高通量篩檢、自動化工作流程和分散測試環境。然而，測試設備的高成本和技術純熟勞工的缺乏正在限制市場的成長。定序成本的持續降低以及可攜式、易於使用的儀器的開發正在開闢新的應用機會，特別是在分散的照護現場環境中。

本研究的主要特點

該報告對全球分子診斷市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球分子診斷市場的主要企業。

本研究涵蓋的主要企業包括 Abbott Laboratories、Becton、Dickinson and Company、Biomerieux SA、Danaher Corporation、Diasorin SPA、Hologic Inc.、QIAGEN NV 和 Roche Diagnostics。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球分子診斷市場的各種策略矩陣，將有助於相關人員做出決策。

Hoffmann-La Roche Ltd
Illumina, Inc.
Hologic, Inc.
Agilent Technologies Inc.
Qiagen NV
Myriad Genetics
Becton, Dickinson and Company
Abbott Laboratories
bioMerieux SA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Danaher Corporation（Beckman Coulter Inc.）
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Johnson & Johnson
Alere Inc.
Cepheid
Gen-Probe Incorporated
LabCorp（Monogram Biosciences）
Novartis AG

第9章分析師建議

第10章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI1545

The global molecular diagnostics market is estimated to be valued at USD 16.33 Billion in 2024 and is expected to reach USD 36.55 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 16.33 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.20%	2031 Value Projection:	US$ 36.55 Bn

Figure. Molecular Diagnostics Market Share (%), By Region 2024

Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.

Market Dynamics:

The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.

Key Features of the Study:

This report provides in-depth analysis of the global molecular diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.

Detailed Segmentation-

By Product Type
- Reagents & Kits
- Instruments
By Application
- Oncology
- Genetic Testing
- Microbiology
- STDs
- Blood Screening
- Virology
- Tissue Typing
- Prenatal Diagnosis
- Others
By End-user
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Point-of-Care Settings
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Players Insights
- Hoffmann-La Roche Ltd
- Illumina, Inc.
- Hologic, Inc.
- Agilent Technologies Inc.
- Qiagen N.V.
- Myriad Genetics
- Becton, Dickinson and Company
- Abbott Laboratories
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter Inc.)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Johnson & Johnson
- Alere Inc.
- Cepheid
- Gen-Probe Incorporated
- LabCorp (Monogram Biosciences)
- Novartis AG

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Molecular Diagnostics Market, By Product Type
- Global Molecular Diagnostics Market, By Application
- Global Molecular Diagnostics Market, By End-User
- Global Molecular Diagnostics Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Molecular Diagnostics Market, By Product Type, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Molecular Diagnostics Market, By Application, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microbiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
STDs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Virology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Tissue Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prenatal Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Molecular Diagnostics Market, By End-User, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Point-of-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Molecular Diagnostics Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
South Africa
North Africa
Central Africa

8. COMPETITIVE LANDSCAPE

Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
bioMerieux SA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Danaher Corporation (Beckman Coulter Inc.)
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Johnson & Johnson
Alere Inc.
Cepheid
Gen-Probe Incorporated
LabCorp (Monogram Biosciences)
Novartis AG